We are live on ! Find out more
ZURAW

Zura Bio Limited Warrants

Delisted

ZURAW was delisted on the 27th of August, 2024.

16 hedge funds and large institutions have $2.56M invested in Zura Bio Limited Warrants in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% less capital invested

Capital invested by funds: $3.11M → $2.56M (-$559K)

36% less funds holding

Funds holding: 2516 (-9)

82% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 11

83% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 6

Holders
16
Holders Change
-9
Holders Change %
-36%
% of All Funds
0.25%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
6
Closed
11
Calls
$75K
Puts
Net Calls
+$75K
Net Calls Change
+$26K
Name Holding Trade Value Shares
Change
Change in
Stake
GCIA
26
Gabelli & Co Investment Advisers
New York
-$6.86K -45,700 Closed
SAMU
27
SONA Asset Management (US)
New York
-$3.67K -24,480 Closed
CCM
28
Context Capital Management
California
-$4K -23,700 Closed

ZURAW Hedge Fund Activity: Q1 2023 in Review

16 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Zura Bio Limited Warrants (ZURAW) for Q1 2023, worth a combined $2.56M — down 18% from $3.11M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of ZURAW and 2 opened new positions — a net loss of 9 holders — while 6 trimmed existing stakes and 1 added.

The largest buyer was Ionic Capital Management, opening a new position worth an estimated $34K. The largest seller was Calamos Advisors, exiting entirely with an estimated $30K sold.

  • 16 institutional investors held Zura Bio Limited Warrants (ZURAW) as of Q1 2023, down from 25 in Q4 2022.
  • Funds reported $2.56M of Zura Bio Limited Warrants stock for Q1 2023, down 18% quarter-over-quarter.
  • 2 funds opened new Zura Bio Limited Warrants positions in Q1 2023 and 11 closed out, a net change of -9 holders.
  • The largest Zura Bio Limited Warrants buyer in Q1 2023 was Ionic Capital Management, an estimated $34K added.
  • The largest Zura Bio Limited Warrants seller in Q1 2023 was Calamos Advisors, an estimated $30K sold.

Based on aggregated 13F filings for Q1 2023.